ENVB · Enveric Biosciences, Inc.
$1.37
+0.00 (+0.00%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements. ... As a result of these factors, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern for a period of one year after the date of the unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.13M
Shares
4.48M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ENVB
4 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | PSIL | 35,417 | $48,875 | 0.11% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 11,555 | $26,577 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 14,912 | $20,579 | 0.00% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 911 | $2,095 | 0.00% | Long | 2026-05-31 |
Showing 1–4 of 4 positions
Key facts
CIK
890821
CUSIP
29405E505
13F (30d)
26 filings
25 filers
Visit website
Investor relations